Scholars Central

Mini reviewPublished 30 Apr 2024

Biopharmaceuticals' Immunogenicity

Authors: Laurie Corkins

Department of Pharmacology, Tritiny College of Dublin, United Kingdom

Clinical Pharmacology & Biopharmaceutics

Volume 13 · Issue 4 · Pages 01–02

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Biopharmaceuticals have revolutionized healthcare by offering targeted and efficacious treatment options for a myriad of diseases. However, concerns about their high costs and affordability have sparked discussions about their cost-effectiveness. This abstract provides a succinct overview of the complex interplay between innovation and affordability in the realm of biopharmaceuticals, examining the factors influencing pricing, economic impact, and strategies for achieving sustainable healthcare delivery.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Clinical Pharmacology & Biopharmaceutics.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Pharmacology & Biopharmaceutics
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Laurie Corkins”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels